A Journey Into Participation Patterns Among Metastatic Prostate Cancer Patients

Power Life Sciences

Status: Not yet enrolling

Conditions: Metastatic Prostate Cancer

Study type: Observational

Funder types: Industry

Identifiers

NCT06009549

88079658

Details and patient eligibility

About

Taking part in clinical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups.

This research will admit a wide range of data on the clinical study experience of metastatic prostate cancer patients to determine which factors prevail in limiting a patient's ability to join or finish a trial.

It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future patients with metastatic prostate cancer.

Enrollment: 500 estimated patients

Sex: Male

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient is at least 18 years of age
• Diagnosis of metastatic prostate cancer
• Ability to understand and the willingness to sign a written informed consent document

Exclusion criteria

• Enrolled in another research study
• Patients with psychiatric illness/social situations that would limit compliance with study requirements
• Inability to provide written informed consent

Trial design